Tusamitamab ravtansine (SAR-408701) 是一种 DM4 (HY-12454) 抗CEACAM5抗体-药物偶联物 (ADC)。Tusamitamab ravtansine 由结合癌胚抗原相关细胞粘附分子-5 (CEACAM5) 的人源化单克隆抗体和选择性靶向表达 CEACAM5 的肿瘤细胞的细胞毒性美登木素生物碱组成。
| 生物活性 | Tusamitamab ravtansine (SAR-408701) is aDM4(HY-12454) anti-CEACAM5antibody-drug conjugate (ADC). Tusamitamab ravtansine is composed of a humanized monoclonal antibody that binds carcinoembryonic antigen-related cell adhesion molecule-5 (CEACAM5) and a cytotoxic maytansinoid that selectively targets CEACAM5-expressing tumor cells[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com